According to GlobalData’s medical device pipeline database, 0 Troponin Tests devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.

Smarter leaders trust GlobalData

All 0 devices of this category are in active stage of development.

Troponin Tests are carried out to measure Troponin, a regulatory protein that is uniquely present on striated muscle and which regulates the calcium-mediated interaction of actin and myosin. Cardiac troponins have additional amino acid residues on the N-terminal region of the protein, which is not present on the skeletal forms, which makes them a promising analyte protein for indicating cardiac specificity. Cardiac troponin I is released rapidly (approx. hrs.) to a detectable level after the onset of acute myocardial infarction.

Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.

Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Troponin Tests pipeline devices are all expected to be approved within the next ten years.

Currently, private organizations, public entities and institutions are working on the development of Troponin Tests devices. Overall, most of these Troponin Tests pipeline devices are being developed by private entities.

For a complete picture of the developmental pipeline for Troponin Tests devices, buy the report here.

Premium Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.